Trial intelligence / Profile preview

Safety and Sensitization Study of LtSTA in Healthy Volunteers

NCT00633009Phase 2Completed

Sponsor
Nielsen BioSciences, Inc.
Start
Aug 2008
Primary completion
Sep 2009
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of Leishmania tropica skin test antigen in cutaneous leishmaniasis (CL), sponsored by Nielsen BioSciences, Inc.. Started Aug 2008; status: completed.

02

Drugs

Leishmania tropica skin test antigen
03

Conditions

cutaneous leishmaniasis (CL)

Beyond the preview

Go deeper on NCT00633009.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00633009.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call